ArticleFrontiers in immunology2025

Secukinumab-induced Crohn's disease in a psoriasis patient: a case report highlighting paradoxical reactions to IL-17 inhibition.

Huiling Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.